角膜塑形术控制儿童近视有效性与安全性的Meta分析

doi:10.6040/j.issn.1673-3770.0.2021.037

摘要/Abstract

摘要： 目的评价不同治疗时长的角膜塑形术(OK)延缓学龄儿童近视进展的有效性及安全性。方法系统检索了PubMed、Cochrane Library、Embase、OVID、中国知网(CNKI)、万方数据库、维普中文期刊数据库(VIP)及中国生物医学文献服务系统(CBM)中随机对照试验(RCT)和前瞻性非随机对照研究(PNC),检索时限为建库至2020年10月31日,结果不受语言限制。2位研究者按照纳入和排除标准进行文献筛选、数据提取及质量评价。使用Rev Man5.3版软件对符合标准的文献进行统计分析。结果共纳入4项RCT和12项PNC,涉及1 453名学龄儿童。OK组在0.5年、1年、1.5年、2年随访期延缓眼轴增长方面均有显著差异［0.5年:MD:-0.10 mm,95%CI(-0.12,-0.08),P<0.001;1年:MD:-0.18 mm,95%CI(-0.19,-0.17),P<0.000 1;1.5年:MD:-0.21 mm,95%CI(-0.26,-0.15),P<0.000 1;2年:MD:-0.26 mm,95%CI(-0.30,-0.22),P<0.001］。近视控制比率随着治疗持续时间的延长而降低。0.5年随访期,OK对东亚儿童的眼轴延长减缓效果优于白种儿童,其余随访期两种族均无统计学差异(P>0.05)。随访2年OK组和对照组不良事件发生率的RR=5.75,95%CI(2.23,14.81),P=0.000 3。结论角膜塑形镜是控制学龄儿童近视进展的有效、安全的方法,但仍需要更多长期RCT研究评价其持续有效性。

关键词: 角膜塑形术, 近视, 学龄儿童, 近视控制, 眼轴长度, Meta分析

Abstract: Objective To access the effectiveness and safety of orthokeratology(OK)on slowing myopia progression in school-aged children in different treatment duration. Methods PubMed, Cochrane Library, Embase, OVID, CNKI, Wanfang database, VIP, and CBM were searched, including randomized controlled trials(RCT)and prospective non-randomized control studies(PNC). Two reviewers independently screened literature, extracted data, and assessed the quality of included studies. The Meta-analysis was performed using RevMan 5.3 version for statistical analysis. Results 4 RCTs and 12 PNCs involving 1 453 participants were included. There were significant differences in the effect of OK group versus control group on slowing axial elongation at 0.5, 1, 1.5, 2 years follow-up periods(0.5a:MD:-0.10 mm, 95%CI: -0.12 to -0.08, P<0.001; 1a: MD: -0.18 mm, 95%CI:-0.19 to -0.17, P<0.001; 1.5a: MD: -0.21 mm, 95%CI: -0.26 to -0.15, P<0.001; 2a: MD:-0.26 mm, 95%CI: -0.30 to -0.22, P<0.001). The myopia control rate decreased with the duration of treatment. Except for the 0.5 years follow-up period, when the effect of OK lens on the reduction of axial elongation in Asian children was better than that in Caucasian, there was no statistical difference in other follow-up periods(P>0.05). The RR of incidence of adverse events in the OK and the control groups at 2-year was 5.75(95%CI:2.23 to 14.81, P=0.000 3). Conclusion Orthokeratology is an effective and safe method on controlling the progression of myopia for school-aged children. However, long-term and additional RCT studies are required to find out its continuing effectiveness.

Key words: Orthokeratology, Myopia, School-aged Children, Myopia control, Axial length, Meta-analysis

中图分类号:

R778.1

刘艺,于明坤,孙伟,邵震,胡媛媛,毕宏生. 角膜塑形术控制儿童近视有效性与安全性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 92-100.

LIU Yi, YU Mingkun, SUN Wei, SHAO Zhen, HU Yuanyuan, BI Hongsheng. The effectiveness and safety of orthokeratology on controlling myopia of children: a meta-analysis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(6): 92-100.

参考文献

[1] Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050[J]. Ophthalmology, 2016, 123(5): 1036-1042. doi:10.1016/j.ophtha.2016.01.006.
[2] Vagge A, Ferro Desideri L, Nucci P, et al. Prevention of progression in myopia: a systematic review[J]. Diseases, 2018, 6(4): 92. doi:10.3390/diseases6040092.
[3] Morgan IG, French AN, Ashby RS, et al. The epidemics of myopia: Aetiology and prevention[J]. Prog Retin Eye Res, 2018, 62: 134-149. doi:10.1016/j.preteyeres.2017.09.004.
[4] Cho P, Tan Q. Myopia and orthokeratology for myopia control[J]. Clin Exp Optom, 2019, 102(4): 364-377. doi:10.1111/cxo.12839.
[5] P rssinen O, Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood[J]. Acta Ophthalmol, 2019, 97(5): 510-518. doi:10.1111/aos.13964.
[6] 边思林, 刘华, 林江. 近视儿童角膜塑形镜与框架眼镜配戴一年临床效果的随机对照研究[J]. 中华实验眼科杂志, 2020, 38(2): 121-127. doi:10.3760/cma.j.issn.2095-0160.2020.02.008. BIAN Silin, LIU Hua, LIN Jiang. A randomized-controlled clinical study of one-year outcome between orthokeratology contact lens wear and glasses wear in myopic children[J]. Chinese Journal of Experimental Ophthalmology, 2020,38(2): 121-127. doi:10.3760/cma.j.issn.2095-0160.2020.02.008.
[7] Lyu TB, Wang LY, Zhou LT, et al. Regimen study of high myopia-partial reduction orthokeratology[J]. Eye Contact Lens: Sci Clin Pract, 2020, 46(3): 141-146. doi:10.1097/icl.0000000000000629.
[8] Charm J, Cho P. High myopia-partial reduction ortho-k: a 2-year randomized study[J]. Optom Vis Sci, 2013, 90(6): 530-539. doi:10.1097/opx.0b013e318293657d.
[9] Cho P, Cheung SW. Retardation of myopia in Orthokeratology(ROMIO)study: a 2-year randomized clinical trial[J]. Invest Ophthalmol Vis Sci, 2012, 53(11): 7077-7085. doi:10.1167/iovs.12-10565.
[10] 姜瑾. 角膜塑形镜、低浓度阿托品与框架眼镜控制青少年近视的疗效比较[J]. 国际眼科杂志, 2018, 18(7): 1349-1352. doi:10.3980/j.issn.1672-5123.2018.7.46. JIANG Jin. Effect of orthokeratology, low concentration atropine and frame glasses on juvenile myopia prevention and control[J]. International Eye Science, 2018, 18(7): 1349-1352. doi:10.3980/j.issn.1672-5123.2018.7.46.
[11] 李秀红, 钟梅, 朱豫, 等. 角膜塑形术在青少年近视控制中的作用[J]. 中华眼外伤职业眼病杂志, 2017, 39(7): 491-495. doi:10.3760/cma.j.issn.2095-1477.2017.07.003. LI Xiuhong, ZHONG Mei, ZHU Yu, et al. The control effect of orthokeratology on adolescent myopia[J]. Chinese Journal of ocular trauma and occupational eye disease, 2017, 39(7): 491-495. doi:10.3760/cma.j.issn.2095-1477.2017.07.003.
[12] Li Z, Cui D, Hu Y, et al. Choroidal thickness and axial length changes in myopic children treated with orthokeratology[J]. Cont Lens Anterior Eye, 2017, 40(6): 417-423. doi:10.1016/j.clae.2017.09.010.
[13] 符爱存, 吕勇, 姬娜, 等. 角膜塑形镜控制青少年近视进展效果的相关因素[J]. 中华眼视光学与视觉科学杂志, 2016, 18(2): 72-77. doi:10.3760/cma.j.issn.1674-845X.2016.02.003. FU Aicun, LYU Yong, JI Na, et al. Factors preventing myopia progression with orthokeratology correction[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2016, 18(2): 72-77. doi:10.3760/cma.j.issn.1674-845X.2016.02.003.
[14] Pauné J, Morales H, Armengol J, et al. Myopia control with a novel peripheral gradient soft lens and orthokeratology: a 2-year clinical trial[J]. Biomed Res Int, 2015, 2015: 507572. doi:10.1155/2015/507572.
[15] 李斌, 牛燕, 李超, 等. 初发性近视患者配戴角膜塑形镜和框架眼镜的疗效观察[J]. 眼科新进展, 2015, 35(1): 78-80. doi:10.13389/j.cnki.rao.2015.0022. LI Bin, NIU Yan, LI Chao, et al. Clinical observation on orthokeratology and glasses treatment of onset myopia[J]. Recent Advances in Ophthalmology, 2015, 35(1): 78-80. doi:10.13389/j.cnki.rao.2015.0022.
[16] 姜珺, 陈云云, 吴戈, 等. 不同矫正方式对儿童近视控制的效果[J]. 中华眼视光学与视觉科学杂志, 2014, 16(2): 73-77. doi:10.3760/cma.j.issn.1674-845X.2014.02.003. JIANG Jun, CHEN Yunyun, WU Ge, et al. Effect of four types of refractive correction on myopia progression in Chinese children[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2014, 16(2): 73-77. doi:10.3760/cma.j.issn.1674-845X.2014.02.003.
[17] 牛燕, 李斌, 姬娜. 角膜塑形镜治疗青少年中度近视的临床观察[J]. 中华眼视光学与视觉科学杂志, 2014, 16(2): 92-94. doi:10.3760/cma.j.issn.1674-845X.2014.02.008. NIU Yan, LI Bin, JI Na. Clinical assessment of orthokeratology treatment for adolescents with moderate myopia[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2014, 16(2): 92-94. doi:10.3760/cma.j.issn.1674-845X.2014.02.008.
[18] Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology(TO-SEE study)[J]. Invest Ophthalmol Vis Sci, 2013, 54(10): 6510-6517. doi:10.1167/iovs.13-12527.
[19] Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, et al. Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes[J]. Invest Ophthalmol Vis Sci, 2012, 53(8): 5060-5065. doi:10.1167/iovs.11-8005.
[20] Hiraoka T, Kakita T, Okamoto F, et al. Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study[J]. Invest Ophthalmol Vis Sci, 2012, 53(7): 3913-3919. doi:10.1167/iovs.11-8453.
[21] Kakita T, Hiraoka T, Oshika T. Influence of overnight orthokeratology on axial elongation in childhood myopia[J]. Invest Ophthalmol Vis Sci, 2011, 52(5): 2170-2174. doi:10.1167/iovs.10-5485.
[22] Margulis AV, Pladevall M, Riera-Guardia N, et al. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank[J]. Clin Epidemiol, 2014, 6: 359-368. doi:10.2147/clep.s66677.
[23] Naidoo KS, Fricke TR, Frick KD, et al. Potential lost productivity resulting from the global burden of myopia: systematic review, meta-analysis, and modeling[J]. Ophthalmology, 2019, 126(3): 338-346. doi:10.1016/j.ophtha.2018.10.029.
[24] Lee JTL, Guo X, Li Z, et al. Progression and longitudinal biometric changes in highly myopic eyes[J]. Invest Ophthalmol Vis Sci, 2020, 61(4): 34. doi:10.1167/iovs.61.4.34.
[25] Cheng X, Xu J, Brennan NA. Accommodation and its role in myopia progression and control with soft contact lenses[J]. Ophthalmic Physiol Opt, 2019, 39(3): 162-171. doi:10.1111/opo.12614.
[26] Sankaridurg P, Conrad F, Tran H, et al. Controlling progression of myopia: optical and pharmaceutical strategies[J]. Asia Pac J Ophthalmol(Phila), 2018, 7(6): 405-414. doi:10.22608/apo.2018333.
[27] Smith EL, Hung LF, Huang J. Relative peripheral hyperopic defocus alters central refractive development in infant monkeys[J]. Vision Res, 2009, 49(19): 2386-2392. doi:10.1016/j.visres.2009.07.011.
[28] Faria-Ribeiro M, Queirós A, Lopes-Ferreira D, et al. Peripheral refraction and retinal contour in stable and progressive myopia[J]. Optom Vis Sci, 2013, 90(1): 9-15. doi:10.1097/opx.0b013e318278153c.
[29] Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments(DIMS)spectacle lenses slow myopia progression: a 2-year randomised clinical trial[J]. Br J Ophthalmol, 2020, 104(3): 363-368. doi:10.1136/bjophthalmol-2018-313739.
[30] 周珺, 王肖, 吴晓璇, 等. 夜戴型角膜塑形镜矫正青少年近视疗效及其影响因素分析[J]. 中国实用眼科杂志, 2017, 35(2): 136-142. doi:10.3760/cma.j.issn.1006-4443.2017.02.009. ZHOU Jun, WANG Xiao, WU Xiaoxuan, et al. Clinic effect and relevant influencing factors of overninght orthokeratology in myopic adolescent[J]. Chinese Journal of Practical Ophthalmology, 2017, 35(2): 136-142. doi:10.3760/cma.j.issn.1006-4443.2017.02.009.
[31] 郭寅, 刘立洲, 彭丽, 等. 角膜塑形镜去片裸眼视力低下的影响因素及近视控制效果[J]. 中华眼视光学与视觉科学杂志, 2018, 20(12): 743-748. doi:10.3760/cma.j.issn.1674-845X.2018.12.008. GUO Yin, LIU Lizhou, PENG Li, et al. Factors associated with low visual acuity after orthokeratology lens removal and myopia control[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2018, 20(12): 743-748. doi:10.3760/cma.j.issn.1674-845X.2018.12.008.
[32] 张雅娟. 角膜塑形镜联合框架眼镜治疗青少年高度近视的效果[J]. 医疗装备, 2020, 33(14): 72-73.
[33] Sun Y, Xu F, Zhang T, et al. Orthokeratology to control myopia progression: a meta-analysis[J]. PLoS One, 2015, 10(4): e0124535. doi:10.1371/journal.pone.0124535.
[34] Si JK, Tang K, Bi HS, et al. Orthokeratology for myopia control: a meta-analysis[J]. Optom Vis Sci, 2015,92(3):252-257. doi: 10.1097/OPX.0000000000000505.
[35] Li SM, Kang MT, Wu SS, et al. Efficacy, safety and acceptability of orthokeratology on slowing axial elongation in myopic children by meta-analysis[J]. Curr Eye Res, 2016, 41(5): 600-608. doi:10.3109/02713683.2015.1050743.
[36] Wen D, Huang J, Chen H, et al. Efficacy and acceptability of orthokeratology for slowing myopic progression in children: a systematic review and meta-analysis[J]. J Ophthalmol, 2015, 2015: 360806.doi:10.1155/2015/360806.
[37] Cui YH, Li L, Wu Q, et al. Myopia correction in children: a meta-analysis[J]. Clin Investig Med Med Clinique et Exp, 2017, 40(3): E117-E126. doi:10.25011/cim.v40i3.28391.
[38] Prousali E, Haidich AB, Fontalis A, et al. Efficacy and safety of interventions to control myopia progression in children: an overview of systematic reviews and meta-analyses[J]. BMC Ophthalmol, 2019, 19(1): 106. doi:10.1186/s12886-019-1112-3.
[39] Huang JH, Wen DZ, Wang QM, et al. Efficacy comparison of 16 interventions for myopia control in children[J]. Ophthalmology, 2016, 123(4): 697-708. doi:10.1016/j.ophtha.2015.11.010.
[40] 靳敏肖. 角膜塑形镜治疗我国青少年低中度近视患者短期效果观察[J]. 临床合理用药杂志, 2019, 12(8): 155-156. doi:10.15887/j.cnki.13-1389/r.2019.08.103.
[41] 蒋丽君, 朱永唯, 章友美, 等. 角膜塑形镜矫治低中度近视的临床观察[J]. 中国基层医药, 2018, 25(17): 2236-2239. doi:10.3760/cma.j.issn.1008-6706.2018.17.015. JIANG Lijun, ZHU Yongwei, ZHANG Youmei, et al. Clinical observation of orthokeratology lens in the treatment of mild and moderate myopia[J]. Chinese Journal of Primary Medicine and Pharmacy, 2018, 25(17): 2236-2239. doi:10.3760/cma.j.issn.1008-6706.2018.17.015.
[42] Jiang J, Lian L, Wang F, et al. Comparison of toric and spherical orthokeratology lenses in patients with astigmatism[J]. J Ophthalmol, 2019, 2019: 4275269. doi:10.1155/2019/4275269.
[43] 李丽, 边思林, 林江. 成都市青羊区3~18岁儿童和青少年屈光状况及眼轴长度的现况分析[J]. 国际眼科杂志, 2021, 21(2): 325-330. doi:10.3980/j.issn.1672-5123.2021.2.27. LI Li, BIAN Silin, LIN Jiang. Current situation of refractive status and axial length in children and adolescents aged 3 - 18 years in Qingyang District of Chengdu[J]. International Eye Science, 2021, 21(2): 325-330. doi:10.3980/j.issn.1672-5123.2021.2.27.
[44] 曹朋, 李惠玲, 周学军. 角膜塑形镜配戴矫治低中高度近视的临床疗效观察[J]. 中国中医眼科杂志, 2019, 29(5): 375-379. doi:10.13444/j.cnki.zgzyykzz.2019.05.008. CAO Peng, LI Huiling, ZHOU Xuejun. Clinical observation of orthokeratology on low, moderate and high myopia[J]. China Journal of Chinese Ophthalmology, 2019, 29(5): 375-379. doi:10.13444/j.cnki.zgzyykzz.2019.05.008.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed